Rexulti 0.5 MG tablet 30S

Ended Awarded Last action

Contract number
SPE2DR26FPY4Y
Awardee
Awarding agency
Obligated
$17,008

Award facts

Contract value 100% obligated
$17,008.29 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $17,008.29 delivery order to Amerisourcebergen Drug Corp on March 13, 2026, for REXULTI 0.5 mg tablets (30-count units), with an ultimate completion date of March 16, 2026.

Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside. The parent vehicle is the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), valued at up to $999,999,999.00 and running through December 2026, which supports global pharmaceutical supply to military healthcare programs.

Quick answers

Who was awarded contract SPE2DR26FPY4Y?

SPE2DR26FPY4Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 13, 2026.

How much is contract SPE2DR26FPY4Y worth?

The government has obligated $17,008 on SPE2DR26FPY4Y.

Is contract SPE2DR26FPY4Y an order under another contract?

Yes. SPE2DR26FPY4Y is a delivery order under SPE2DR25D1034, an indefinite delivery contract.

Was contract SPE2DR26FPY4Y competed?

The extent of competition for SPE2DR26FPY4Y was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award